Início › Câncer de Ovário › New Jersey › Edison
Ensaios clínicos de Câncer de Ovário em Edison, NJ
20 estudos para Câncer de Ovário estão buscando participantes em locais em Edison e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecrutandoFase 2
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
- Robert Wood Johnson University Hospital Somerset, Somerville · a 11 mi de distância
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- START New Jersey, East Brunswick · a 6 mi de distância
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RecrutandoFase 1
- Research Site, New Brunswick · a 3 mi de distância
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecrutandoFase 2
- Rutgers Cancer Institute of New Jersey /ID# 274358, New Brunswick · a 3 mi de distância
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RecrutandoFase 2
- Research Site, East Brunswick · a 6 mi de distância
A Study of Isoquercetin in People With Ovarian Cancer
RecrutandoFase 2
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge · a 15 mi de distância
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
RecrutandoFase 1/2
- START New Jersey East Brunswick, East Brunswick · a 6 mi de distância
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RecrutandoEstudo observacional
- Astera Cancer Care, East Brunswick · a 6 mi de distância
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RecrutandoFase 1
- START - New Jersey, East Brunswick · a 6 mi de distância
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RecrutandoFase 3
- Rutgers Cancer Institute of New Jersey ( Site 0071), New Brunswick · a 3 mi de distância
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
RecrutandoFase 1/2
- Start Njeb, East Brunswick · a 6 mi de distância
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
RecrutandoFase 2/3
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
- Memorial Sloan Kettering Basking Ridge, Basking Ridge · a 15 mi de distância
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Recrutando
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
- Virtua Voorhees, Voorhees Township · a 5 mi de distância
- Robert Wood Johnson University Hospital Somerset, Somerville · a 11 mi de distância
- e mais 1
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecrutandoFase 3
- Rutgers Cancer Institute of New Jersey, New Brunswick · a 3 mi de distância
- Robert Wood Johnson University Hospital Somerset, Somerville · a 11 mi de distância
- Summit Medical Group, Berkeley Heights · a 11 mi de distância
- e mais 1
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
Recrutando
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi de distância
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
RecrutandoFase 2
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi de distância
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
RecrutandoFase 1
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · a 15 mi de distância
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
RecrutandoFase 2
- Rutgers Cancer Institute, New Brunswick · a 3 mi de distância
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, New Brunswick · a 3 mi de distância
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
RecrutandoFase 1
- Exelixis Clinical Site #9, New Brunswick · a 3 mi de distância
Ensaios de Câncer de Ovário em outras cidades
- Houston, TX89 estudos
- New York City, NY69 estudos
- Boston, MA61 estudos
- Los Angeles, CA50 estudos
- Nashville, TN49 estudos
- Arlington, VA46 estudos
- Philadelphia, PA44 estudos
- Columbus, OH39 estudos
- St. Louis, MO38 estudos
- Chicago, IL36 estudos
- San Antonio, TX31 estudos
- Cleveland, OH30 estudos
Outros estudos em Edison
- Câncer de Mama68 estudos
- Câncer de Pulmão de Não Pequenas Células47 estudos
- Câncer (todos os tipos)33 estudos
- Câncer de Próstata29 estudos
- Câncer Colorretal23 estudos
- Câncer de Pulmão23 estudos
- Mieloma Múltiplo22 estudos
- Câncer de Bexiga21 estudos
- Câncer Metastático20 estudos
- Leucemia Mieloide Aguda20 estudos
- Câncer Endometrial19 estudos
- Carcinoma urotelial (células de transição)18 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.